Hospitalized Patients With and Without Hemodialysis Have Markedly Different Vancomycin Pharmacokinetics: A Population Pharmacokinetic Model-Based Analysis.

Therapeutic Drug Monitoring
Vineet GotiJesse T Jacob

Abstract

Despite being in clinical use for about 6 decades, vancomycin dosing remains perplexing and complex. A population pharmacokinetic modeling and simulation approach was used to evaluate the efficiency of the current nomogram-based dosing of vancomycin. Serum vancomycin concentrations were obtained as a part of routine therapeutic drug monitoring from two 500-bed academic medical centers. A population pharmacokinetic model was first built using these therapeutic drug monitoring data. Population pharmacokinetic modeling was conducted using NONMEM (7.2 and 7.3). The forward addition-backward elimination approach was used to test the covariate effects. Appropriate numerical and visual criteria were used as model diagnostics for checking model appropriateness and model qualification. The current nomogram efficiency was evaluated by determining the percentage of subjects in the therapeutic range (10-20 mg/L). A 2-compartment model with between-subject variability on clearance (CL), central volume of distribution (Vc), and peripheral volume of distribution best fit the data. Blood urea nitrogen, age, creatinine clearance, and hemodialysis status were significant covariates on clearance. Hemodialysis status was a significant covariate on...Continue Reading

References

Jan 1, 1976·Nephron·D W Cockcroft, M H Gault
Jun 1, 1988·Antimicrobial Agents and Chemotherapy·K A RodvoldL J Riff
Dec 1, 1984·The Journal of Antimicrobial Chemotherapy·J J GaraudF Vachon
Apr 1, 1984·Antimicrobial Agents and Chemotherapy·G R MatzkeW F Keane
Apr 1, 1983·Antimicrobial Agents and Chemotherapy·N BrownG P Bodey
Apr 1, 1982·Antimicrobial Agents and Chemotherapy·R A BlouinW O Griffen
Sep 1, 1982·Antimicrobial Agents and Chemotherapy·J C RotschaferL D Solem
Nov 1, 1981·Reviews of Infectious Diseases·R C MoelleringD J Greenblatt
Nov 1, 1981·Reviews of Infectious Diseases·B A CunhaC H Nightingale
Apr 1, 1980·Journal of Clinical Pharmacology·D J KrogstadD J Greenblatt
Feb 25, 1998·Clinical Pharmacokinetics·B M PowerK F Ilett
Apr 29, 1998·Therapeutic Drug Monitoring·M YasuharaR Hori
Apr 9, 1999·Computer Methods and Programs in Biomedicine·E N Jonsson, M O Karlsson
Apr 24, 1999·Computer Methods and Programs in Biomedicine·J ParkeB G Charles
Jun 26, 1999·British Journal of Clinical Pharmacology·C M KirkpatrickE J Begg
Dec 19, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·S K Fridkin
Jan 5, 2002·Journal of Pharmacokinetics and Pharmacodynamics·S L Beal
Jul 27, 2002·ASAIO Journal : a Peer-reviewed Journal of the American Society for Artificial Internal Organs·Suma PrakashRobert M Lindsay
Sep 13, 2002·Critical Care : the Official Journal of the Critical Care Forum·Vincent Launay-VacherGilbert Deray
Jul 19, 2005·Computer Methods and Programs in Biomedicine·Lars LindbomNiclas Jonsson
Aug 27, 2005·British Journal of Clinical Pharmacology·Hussain Mulla, Suneel Pooboni
Sep 9, 2006·Journal of Clinical Pharmacy and Therapeutics·P Llopis-Salvia, N V Jiménez-Torres
Dec 14, 2006·Intensive Care Medicine·Maria del Mar Fernández de Gatta GarciaAmparo Sánchez Navarro
Jul 7, 2007·Pharmaceutical Research·Andrew C HookerMats O Karlsson
Feb 25, 2009·Critical Care Medicine·Jason A Roberts, Jeffrey Lipman
Mar 21, 2009·The Journal of Antimicrobial Chemotherapy·A H ThomsonA M Lovering
Oct 31, 2009·Burns : Journal of the International Society for Burn Injuries·Michael DoltonAndrew J McLachlan
Jul 24, 2010·International Journal of Clinical Pharmacology and Therapeutics·J L SánchezJ M Cornejo-Bravo
Sep 8, 2010·The Journal of Antimicrobial Chemotherapy·Kichan DohDong-Seok Yim
Feb 23, 2011·Seminars in Dialysis·Stefaan J Vandecasteele, An S De Vriese
Jun 1, 2011·Journal of Pharmacokinetics and Pharmacodynamics·Xu Steven XuAn Vermeulen
Dec 14, 2011·Clinical Pharmacokinetics·Amélie MarsotNicolas Simon
May 11, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Sheryl A ZelenitskyLavern M Vercaigne

❮ Previous
Next ❯

Citations

Mar 22, 2019·Pharmacotherapy·Robert C McLeay
Aug 14, 2020·The Journal of Antimicrobial Chemotherapy·Rashmi V ShingdeSophie L Stocker
Feb 6, 2020·Clinical Pharmacokinetics·Abdullah AljutayliFahima Nekka
Sep 19, 2020·Therapeutic Drug Monitoring·Siriluk JaisuePakawadee Sermsappasuk
Apr 2, 2021·British Journal of Clinical Pharmacology·Stephanie A RoydhouseSophie L Stocker
May 4, 2021·Critical Care Medicine·Sujita W NarayanAsad E Patanwala
Sep 17, 2021·Critical Care Medicine·Alexander H FlanneryRyan P Mynatt
Oct 2, 2021·European Journal of Clinical Pharmacology·Maria SwartlingElisabet I Nielsen
Dec 4, 2021·Frontiers in Pharmacology·Muhammad Muaaz MunirMuhammad Usman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.